(Q45238669)

11 December 2017

title

Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients (English)

1 reference

11 December 2017

main subject

coronary artery disease

1 reference

1

1 reference

11 December 2017

Dimitri P Mikhailidis

9

object named as

Dimitri P Mikhailidis

1 reference

11 December 2017

Efstathios D Pagourelias

6

object named as

Efstathios Pagourelias

1 reference

11 December 2017

Anna I Kakafika

2

1 reference

11 December 2017

Athanasios A Papageorgiou

3

1 reference

11 December 2017

Konstantinos Tziomalos

4

1 reference

11 December 2017

Athanasios Skaperdas

5

1 reference

11 December 2017

Athina Pirpasopoulou

7

1 reference

11 December 2017

Asterios Karagiannis

8

1 reference

11 December 2017

GREACE Study Collaborative Group

10

1 reference

11 December 2017

publication date

23 August 2007

1 reference

11 December 2017

1 reference

11 December 2017

volume

42

1 reference

11 December 2017

issue

11

1 reference

11 December 2017

page(s)

999-1009

1 reference

The effect of cholesterol-lowering treatment on renal function

11 December 2017

cites work

1 reference

12 December 2020

Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease

1 reference

12 December 2020

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia

1 reference

12 December 2020

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

1 reference

12 December 2020

The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).

1 reference

12 December 2020

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

12 December 2020

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

12 December 2020

Plasma triglycerides, an independent predictor of cardiovascular disease in men: a prospective study based on a population with prevalent metabolic syndrome

1 reference

12 December 2020

Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles

1 reference

12 December 2020

Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles

1 reference

12 December 2020

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

12 December 2020

Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease

1 reference

12 December 2020

Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects

1 reference

12 December 2020

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.

1 reference

12 December 2020

The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study.

1 reference

12 December 2020

Non-high density lipoprotein cholesterol and coronary events during long-term statin treatment

1 reference

12 December 2020

Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study

1 reference

12 December 2020

Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).

1 reference

12 December 2020

Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe

1 reference

12 December 2020

The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations

1 reference

12 December 2020

Clinical relevance of postprandial lipaemia

1 reference

12 December 2020

Plasma triglyceride level and mortality from coronary heart disease

1 reference

12 December 2020

Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

1 reference

12 December 2020

Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart study

1 reference

12 December 2020

Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.

1 reference

12 December 2020

Role of fibrates in reducing coronary risk: a UK Consensus

1 reference

12 December 2020

Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects

1 reference

12 December 2020

Comparison of statins in hypertriglyceridemia

1 reference

12 December 2020

Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

1 reference

12 December 2020

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

12 December 2020

Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes

1 reference

12 December 2020

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice

1 reference

12 December 2020

Early vascular benefits of statin therapy

1 reference

12 December 2020

The triglyceride issue: a view from Framingham

1 reference

12 December 2020

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

12 December 2020

Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease

1 reference

12 December 2020

10.1007/S11745-007-3103-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

1030343003

0 references

1 reference